During the past decade, Specjalistyczny Gabinet Ginekologiczno-Polozniczy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Specjalistyczny Gabinet Ginekologiczno-Polozniczy" are "Endometriosis" (2 trials), "Uterine Fibroids" (2 trials) and "Leiomyoma" (1 trials). Many other conditions were trialed in "Specjalistyczny Gabinet Ginekologiczno-Polozniczy" in a lesser frequency.

Most popular intervention types in "Specjalistyczny Gabinet Ginekologiczno-Polozniczy" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vilaprisan (BAY1002670)" (2 trials), "BAY1128688" (1 trials), "BAY1817080" (1 trials) and "Elagolix" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specjalistyczny Gabinet Ginekologiczno-Polozniczy" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Specjalistyczny Gabinet Ginekologiczno-Polozniczy". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Specjalistyczny Gabinet Ginekologiczno-Polozniczy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Specjalistyczny Gabinet Ginekologiczno-Polozniczy, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".